We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Lung Fibrosis Is Linked to Increased Endothelial Cell Activation and Dysfunctional Vascular Barrier Integrity.
- Authors
Fließer, Elisabeth; Jandl, Katharina; Lins, Thomas; Birnhuber, Anna; Valzano, Francesco; Kolb, Dagmar; Foris, Vasile; Heinemann, Akos; Olschewski, Horst; Evermann, Matthias; Hoetzenecker, Konrad; Kreuter, Michael; Voelkel, Norbert F.; Marsh, Leigh M.; Wygrecka, Malgorzata; Kwapiszewska, Grazyna
- Abstract
Pulmonary fibrosis (PF) can be a fatal disease characterized by progressive lung scarring. It is still poorly understood how the pulmonary endothelium is involved in the disease pathogenesis. Differences of the pulmonary vasculature between patients and donors were analyzed using transmission electron microscopy, immunohistochemistry, and single-cell RNA sequencing. Vascular barrier resistance, endothelial–immune cell adhesion, and sensitivity to an inflammatory milieu were studied in vitro. Integrity and activation markers were measured by ELISA in human plasma. Transmission electron microscopy demonstrated abnormally swollen endothelial cells (ECs) in fibrotic lungs compared with donors. A more intense CD31 and von Willebrand Factor (vWF) and patchy vascular endothelial (VE)-Cadherin staining in fibrotic lungs supported the presence of a dysregulated endothelium. Integrity markers CD31, VE-Cadherin, Thrombomodulin, and VEGFR-2 (vascular endothelial growth factor receptor-2) and activation marker vWF gene expression was increased in different endothelial subpopulations (e.g., arterial, venous, general capillary, aerocytes) in PF. This was associated with a heightened sensitivity of fibrotic ECs to TNF-α or IFN-γ and elevated immune cell adhesion. The barrier strength was overall reduced in ECs from fibrotic lungs. vWF and IL-8 were increased in the plasma of patients, whereas VE-Cadherin, Thrombomodulin, and VEGFR-2 were decreased. VE-Cadherin staining was also patchy in biopsy tissue and was decreased in plasma samples of patients with PF 6 months after the initial diagnosis. Our data demonstrate highly abnormal ECs in PF. The vascular compartment is characterized by hyperactivation and increased immune cell adhesion, as well as dysfunctional endothelial barrier function. Reestablishing EC homeostasis and function might represent a new therapeutic option for fibrotic lung diseases.
- Subjects
VASCULAR endothelial growth factors; PULMONARY fibrosis; TRANSMISSION electron microscopy; VON Willebrand factor; LUNG diseases; LUNGS
- Publication
American Journal of Respiratory Cell & Molecular Biology, 2024, Vol 71, Issue 3, p318
- ISSN
1044-1549
- Publication type
Article
- DOI
10.1165/rcmb.2024-0046OC